Back to top
more

Omnicell (OMCL)

(Delayed Data from NSDQ)

$50.14 USD

50.14
466,690

-2.32 (-4.42%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $50.16 +0.02 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 250)

Industry: Medical Info Systems

Zacks News

Omnicell (OMCL) Looks Good: Stock Adds 5% in Session

Omnicell (OMCL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Omnicell (OMCL) Q3 Earnings Top, Pre-COVID-19 View Reinstated

Omnicell's (OMCL) Service and other revenues improve in Q3 despite the pandemic-led business challenges.

Omnicell (OMCL) Tops Q3 Earnings and Revenue Estimates

Omnicell (OMCL) delivered earnings and revenue surprises of 20.00% and 2.39%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out for

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CPSI vs. OMCL: Which Stock Should Value Investors Buy Now?

CPSI vs. OMCL: Which Stock Is the Better Value Option?

Omnicell (OMCL) Down 7.7% Since Last Earnings Report: Can It Rebound?

Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Omnicell (OMCL) Hurt by Coronavirus-Led Lower Product Booking

Omnicell (OMCL) is currently witnessing slowdown in purchasing decisions by hospitals.

Omnicell, Pharmaceutical Strategies Enter Acquisition Deal

Omnicell (OMCL) expands pharmacy supply chain capabilities for better management of 340B programs through the buyout of PSG's 340B Link business.

Omnicell (OMCL) Q2 Earnings Lag Estimates, Margins Down

Omnicell's (OMCL) second-quarter revenues suffered due to slowdown in hospital purchasing decisions and product bookings owing to pandemic-led business disruptions.

Omnicell (OMCL) Q2 Earnings Lag Estimates

Omnicell (OMCL) delivered earnings and revenue surprises of -13.95% and 0.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out for

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for June 25th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

HMSY or OMCL: Which Is the Better Value Stock Right Now?

HMSY vs. OMCL: Which Stock Is the Better Value Option?

Omnicell (OMCL) Q1 Earnings Top, Operating Margin Rises

Omnicell's (OMCL) Q1 revenues suffer due to slowdown in hospital purchasing decisions and product bookings.

Earnings Preview: Omnicell (OMCL) Q1 Earnings Expected to Decline

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out for

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CPSI or OMCL: Which Is the Better Value Stock Right Now?

CPSI vs. OMCL: Which Stock Is the Better Value Option?

CPSI or OMCL: Which Is the Better Value Stock Right Now?

CPSI vs. OMCL: Which Stock Is the Better Value Option?

Why You Shouldn't Bet Against Omnicell (OMCL) Stock

Omnicell (OMCL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Why Is Omnicell (OMCL) Down 5% Since Last Earnings Report?

Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Hold on to Omnicell (OMCL) Stock Now

Investors continue to be optimistic about Omnicell (OMCL) on its strong segmental performance in Q4.

Omnicell-Geisinger Deal Improves Patient Care via Automation

Omnicell's (OMCL) XT series Automated Dispensing Systems partners with Geisinger to streamline nursing workflow and improve patient care.

Omnicell (OMCL) Lags Q4 Earnings Estimates, Beats on Revenues

Omnicell (OMCL) fourth-quarter 2019 results reflect strong segmental performances.